KI-Beratung Beta

Produktbild: Current Approaches to Overcome Therapeutic Resistance of Leukemia
Vorbesteller Neu

Current Approaches to Overcome Therapeutic Resistance of Leukemia

222,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Portrait

Zhe-Sheng Chen, PhD., opened the St. John’s University’s first cancer pharmacology laboratory. His research interest is multidrug resistance and its reversal, novel anti-cancer drug development. Chen has over 170 papers published, co-edited Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy book (Elsevier), and holds several patents.

Dr. Saurabh Kumar Jha is an Assistant Professor in the Department of Stem Cell Biology at Kalindi College, University of Delhi. He holds an M.Sc. in Biotechnology from VIT University, Vellore, and a Ph.D. in Biotechnology (Neurobiology) from Delhi Technological University. His research focuses on stem cell biology, with particular expertise in molecular chaperones, ubiquitin E3 ligases, and biomolecular therapeutics in neurodegenerative disorders and aging. Dr. Jha has an extensive publication record, with hundreds of research articles in high-impact international journals and multiple book chapters with leading academic publishers. He is the recipient of the Best Stem Cell Researcher Award (2019). He has actively contributed to curriculum development and has supervised doctoral and master’s students, alongside participating in international conferences and professional societies.

Dr. Neha Gupta is an Assistant Professor in Biotechnology at Jiwaji University, Gwalior, with a Ph.D. in Biotechnology and extensive experience in research and teaching. She has received multiple awards recognizing her research excellence in biological sciences and has held an international research role in microbiology and molecular biology. Her academic background includes teaching, mentoring postgraduate students, and guiding research projects.

Her scholarly contributions include numerous publications, as well as authorship of a patent, a book, and several book chapters. She has actively participated in national and international conferences. Her research focuses on bioactive compounds derived from food, their biological functions, and the application of advanced screening, bioinformatics, and computational approaches.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.04.2027

Herausgeber

Zhe-Sheng Chen + weitere

Verlag

Elsevier

Seitenzahl

440

Maße (L/B)

23,5/19,1 cm

Gewicht

449 g

Sprache

Englisch

ISBN

978-0-443-55821-4

Portrait

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.04.2027

Herausgeber

Verlag

Elsevier

Seitenzahl

440

Maße (L/B)

23,5/19,1 cm

Gewicht

449 g

Sprache

Englisch

ISBN

978-0-443-55821-4

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Current Approaches to Overcome Therapeutic Resistance of Leukemia
  • Part I: Mechanisms of Resistance
    1. The Biology of Resistance in Leukemia: From Cells to Niches
    2. Leukemia Drug Resistance: Molecular Insights and Pathways

    Part II: Emerging Resistance Mechanisms
    3. Leukemia Resistance Unveiled: Stem Cells, Microenvironment, and Evolving Mechanisms
    4. Non-Genetic and Epigenetic Rewiring in Leukemia Resistance
    5. Epigenetic and Metabolic Drivers of Immune Tolerance and Evasion in Leukemia

    Part III: Breaking the Barrier
    6. Breaking Resistance in Leukemia: CAR-T, PROTACs, and Beyond
    7. Defeating Leukemia Resistance: Emerging Therapeutic Frontiers

    Part IV: Clinical Translation and Future Directions
    8. Clinical Translation of Leukemia Therapies: AI-Driven Drug Discovery and Liquid Biopsy
    9. From Bench to Bedside in Leukemia: AI and Liquid Biopsy in Resistance Management
    10. AI-Enabled Immunotherapy in Leukemia: Emerging Approaches to Combat Resistance